Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Gix Internet Ltd.GIXI · Entity 9041 | Chief Financial Officer | August 31, 2026 | October 13, 2026 |
| QUANTUM X LABS INC.VBIX · Entity 7082 | Director · Chief Executive Officer | June 18, 2024 | March 21, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Gix Internet Ltd.
Report date August 31, 2026 · Filed October 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 11,082 |
Reported balance
Holding disclosure · report date 2026-08-31 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 11,082 |
| Option to Purchase Ordinary SharesSEC Table II · derivative / convertible security · Conversion / exercise price $48.80 · Expires 2029-02-02 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-08-31 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F1: The exercise price of this option, originally denominated in New Israeli Shekels ("NIS") in the amount of NIS 150, is presented in the table in U.S. Dollars ("USD") based on the exchange rate reported by the Bank of Israel on October 7, 2026, which was NIS 3.0740 = USD 1.00. |
| Option to Purchase Ordinary SharesSEC Table II · derivative / convertible security · Conversion / exercise price $34.16 · Expires 2030-06-22 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-08-31 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance Not disclosed F2: The exercise price of this option, originally denominated in NIS in the amount of NIS 105, is presented in the table in USD based on the exchange rate reported by the Bank of Israel on October 7, 2026, which was NIS 3.0740 = USD 1.00. |
Filing footnotes · ownership attribution and instrument terms
F1: The exercise price of this option, originally denominated in New Israeli Shekels ("NIS") in the amount of NIS 150, is presented in the table in U.S. Dollars ("USD") based on the exchange rate reported by the Bank of Israel on October 7, 2026, which was NIS 3.0740 = USD 1.00.
F2: The exercise price of this option, originally denominated in NIS in the amount of NIS 105, is presented in the table in USD based on the exchange rate reported by the Bank of Israel on October 7, 2026, which was NIS 3.0740 = USD 1.00.
QUANTUM X LABS INC.
Report date June 18, 2024 · Filed March 21, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 10,036 |
Reported balance
After 2024-06-18 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-06-18 · Purchase · Acquired 2,518 · Balance 10,036 F1: The shares of common stock were issued by the Company to the reporting person upon the conversion of outstanding interest, at a conversion rate of $1.00, due under a loan provided by the reporting person pursuant to the facility agreement between the Company, the reporting person and the other lenders listed therein (the "Facility Agreement"). F3: Includes a warrant to purchase 5,000 shares of common stock, par value $0.0001 per share, that was previously issued by the Company to the reporting person, which is currently exercisable or exercisable within 60 days of March 21, 2025. |
| Warrant to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $1.00 · Expires 2027-06-18 | Direct | 10,036 |
Reported balance
After 2024-06-18 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-06-18 · Purchase · Acquired 2,518 · Balance 10,036 F2: The warrants to purchase common stock, par value $0.0001 per share was issued by the Company to the reporting person, upon the conversion of outstanding interest, at a conversion rate of $1.00 due under a loan provided by the reporting person pursuant to the Facility Agreement. F3: Includes a warrant to purchase 5,000 shares of common stock, par value $0.0001 per share, that was previously issued by the Company to the reporting person, which is currently exercisable or exercisable within 60 days of March 21, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of common stock were issued by the Company to the reporting person upon the conversion of outstanding interest, at a conversion rate of $1.00, due under a loan provided by the reporting person pursuant to the facility agreement between the Company, the reporting person and the other lenders listed therein (the "Facility Agreement").
F2: The warrants to purchase common stock, par value $0.0001 per share was issued by the Company to the reporting person, upon the conversion of outstanding interest, at a conversion rate of $1.00 due under a loan provided by the reporting person pursuant to the Facility Agreement.
F3: Includes a warrant to purchase 5,000 shares of common stock, par value $0.0001 per share, that was previously issued by the Company to the reporting person, which is currently exercisable or exercisable within 60 days of March 21, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 18, 2024 Filed Mar 21, 2025 10:59 UTC | QUANTUM X LABS INC. VBIX · Entity 7082 | PurchaseWarrant to purchase common stock · Derivative | 2,518 | $1.00 Strike: $1.00 | $2,518.00 |
DisclosureSEC source: 0001493152-25-011071 · ownership.xml · derivative · entry 2 Hadad Amihay · CIK 0001782006 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,036 Underlying: Common Stock · 2,518 shares Expires 2027-06-18 F2 · price: The warrants to purchase common stock, par value $0.0001 per share was issued by the Company to the reporting person, upon the conversion of outstanding interest, at a conversion rate of $1.00 due under a loan provided by the reporting person pursuant to the Facility Agreement. F3 · balance_after: Includes a warrant to purchase 5,000 shares of common stock, par value $0.0001 per share, that was previously issued by the Company to the reporting person, which is currently exercisable or exercisable within 60 days of March 21, 2025. Read SEC document |
| June 18, 2024 Filed Mar 21, 2025 10:59 UTC | QUANTUM X LABS INC. VBIX · Entity 7082 | PurchaseCommon Stock, par value $0.0001 per share | 2,518 | $1.00 | $2,518.00 |
DisclosureSEC source: 0001493152-25-011071 · ownership.xml · nonDerivative · entry 1 Hadad Amihay · CIK 0001782006 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,036 F1 · price: The shares of common stock were issued by the Company to the reporting person upon the conversion of outstanding interest, at a conversion rate of $1.00, due under a loan provided by the reporting person pursuant to the facility agreement between the Company, the reporting person and the other lenders listed therein (the "Facility Agreement"). F3 · balance_after: Includes a warrant to purchase 5,000 shares of common stock, par value $0.0001 per share, that was previously issued by the Company to the reporting person, which is currently exercisable or exercisable within 60 days of March 21, 2025. Read SEC document |
| December 07, 2023 Filed Dec 11, 2023 21:21 UTC | QUANTUM X LABS INC. VBIX · Entity 7082 | PurchaseWarrant to purchase common stock · Derivative | 20,000 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0001493152-23-044391 · ownership.xml · derivative · entry 1 Hadad Amihay · CIK 0001782006 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2025-12-31 F1 · security: The warrant to purchase common stock, par value $0.0001 per share, was issued by the Company to the reporting person pursuant to a loan agreement between Viewbix Ltd., a wholly owned subsidiary of the Company, the reporting person and the other lenders listed therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.